THETA is hiring!
THETA is hiring a Health Economist/Disease Modeller and a Senior Clinical Research Coordinator. See the job postings here!
The Toronto Health Economics and Technology Assessment (THETA) Collaborative is a multi-disciplinary research group supporting effective policy decision-making regarding new drugs and health technologies in Ontario.
More [+]
We do this in several ways:
- synthesizing the best scientific evidence on efficacy, effectiveness, costs, and health-related values
- creating new evidence
- presenting evidence to decision-makers so that scientific evidence and the public's values guide policy decisions, and
- training individuals in the discipline of health technology assessment (HTA).
THETA is funded by the Ontario Ministry of Health and Long-Term Care and works in partnership with the following:
- Institute of Health Policy, Management and Evaluation (IHPME), Faculty of Medicine, University of Toronto (lead academic partner)
- Leslie Dan Faculty of Pharmacy, University of Toronto
- University Health Network, Toronto
- Cancer Care Ontario, Toronto.
THETA was established in July 2007.
Click here to read the latest THETA Annual Report.
Less [-]
Upcoming Events
2012/05/282012 ARCC Conference
Canada's 1st Applied Research in Cancer Control Conference will be held on Monday, May 28, 2012 a ... More [+]t the Hilton Bonaventure Hotel, Montreal, QC. The objective of this conference is to bridge a connection between researchers and decision-makers, using health economics, services, policy and ethics research to improve cancer control and the delivery of cancer care.
Less [-]
2012/05/29CAHSPR Conference 2012
CAHSPR's annual conference is Canada's largest gathering of health care researchers, decision mak ... More [+]ers, and stakeholders. The 2012 conference will engage over 600 delegates in informed discussion and debate about options for achieving sustainable improvements in health care for all.
Less [-]
2012/05/29Evolutions in Network Meta-Analysis
Methods are quickly evolving which enable estimates of efficacy of multiple treatments simultaneo ... More [+]usly or estimates of efficacy in the absence of trials between treatments. At the same time, the Canadian Agency for Drugs and Technology in Health (CADTH) has identified that in estimates of clinical benefit, meta-analysis methods are sometimes not used when they should be, incorrectly done, or not fully and transparently reported.
At this workshop experts will review indirect and mixed treatment comparison approaches to evidence synthesis, how mixed treatment comparison meta-analysis is evolving in Canada, and the status of the development of Canadian guidelines for good research practices for indirect treatment comparisons.
Less [-]
THETA Rounds: 2012/06/01Petros PechlivanoglouIntergrating network meta-analysis and decision analytic modeling in a common framework : 12pm, Health Sciences Building, Rm. 106
May 16, 2012 - © Toronto Health Economics and Technology Assessment Collaborative, 2007-2011